Sera Prognostics, Inc. SEC filings SERA
Sera Prognostics, Inc. has 660 filings in SEC EDGAR's recent list, going back to Nov 21, 2011. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 13, 2024 | — |
| CORRESP | Letter to the SEC | Aug 9, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2024 | — |
| SEC STAFF LETTER | Filing | Jul 14, 2021 | — |
| EFFECT | Filing | Jul 14, 2021 | — |
| CERT | Filing | Jul 14, 2021 | — |
| 8-A12B | Filing | Jul 14, 2021 | — |
| CORRESP | Letter to the SEC | Jul 12, 2021 | — |
| CORRESP | Letter to the SEC | Jul 12, 2021 | — |
| CORRESP | Letter to the SEC | Jun 21, 2021 | — |
| CORRESP | Letter to the SEC | Jun 11, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2021 | — |
| SEC STAFF LETTER | Filing | Jun 3, 2021 | — |
| DRSLTR | Filing | May 27, 2021 | — |
| DRS/A | Filing | May 27, 2021 | — |
| SEC STAFF LETTER | Filing | May 14, 2021 | — |
| UPLOAD | Letter from the SEC | May 14, 2021 | — |
| D/A | Filing | May 11, 2021 | — |
| DRSLTR | Filing | May 5, 2021 | — |
| DRS/A | Filing | May 5, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2021 | — |
| SEC STAFF LETTER | Filing | Apr 26, 2021 | — |
| D | Filing | Apr 5, 2021 | — |
| DRS | Filing | Mar 29, 2021 | — |
| D/A | Filing | Feb 27, 2020 | — |
| D | Filing | Aug 7, 2019 | — |
| D | Filing | Mar 8, 2019 | — |
| D | Filing | Dec 6, 2018 | — |
| D | Filing | Jan 23, 2017 | — |
| D | Filing | Nov 18, 2014 | — |
| D | Filing | Jun 10, 2014 | — |
| D/A | Filing | Mar 13, 2014 | — |
| D | Filing | Oct 2, 2013 | — |
| D/A | Filing | Nov 20, 2012 | — |
| D | Filing | Nov 21, 2011 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- SERA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Salt Lake City, UT
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1534969
- Former names
- SERA PROGNOSTICS, INC. (until Nov 4, 2026)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.